Regulus Therapeutics
RGLS
#7028
Rank
HK$4.40 B
Marketcap
HK$63.63
Share price
0.00%
Change (1 day)
437.68%
Change (1 year)

Regulus Therapeutics (RGLS) - Total liabilities

Total liabilities on the balance sheet as of March 2025 : HK$45.21 Million

According to Regulus Therapeutics's latest financial reports the company's total liabilities are HK$45.21 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Regulus Therapeutics - Total liabilities on balance sheet (from 2011 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31HK$60.34 M-19.2%
2023-12-31HK$74.68 M-28.8%
2022-12-31HK$0.10 B-0.33%
2021-12-31HK$0.10 B17.25%
2020-12-31HK$89.75 M-47.77%
2019-12-31HK$0.17 B-35.04%
2018-12-31HK$0.26 B-20.51%
2017-12-31HK$0.33 B-3.75%
2016-12-31HK$0.34 B162.32%
2015-12-31HK$0.13 B-56.94%
2014-12-31HK$0.30 B33.33%
2013-12-31HK$0.22 B-28.5%
2012-12-31HK$0.32 B-51%
2011-12-31HK$0.65 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
GSK plc
GSK
HK$477.88 B 1,056,892.07%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sanofi
SNY
HK$514.87 B 1,138,690.96%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
HK$85.77 B 189,620.59%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$534.03 B 1,181,083.17%๐Ÿ‡ฌ๐Ÿ‡ง UK
Alnylam Pharmaceuticals
ALNY
HK$36.00 B 79,544.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
HK$0.64 B 1,321.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$610.48 B 1,350,175.96%๐Ÿ‡บ๐Ÿ‡ธ USA